Opaleye Management reports acquisition of $33,019.2755 in Grace Therapeutics common shares
GRCE•Opaleye Management, a 10% owner of Grace Therapeutics, purchased 18,442 common shares, increasing its indirectly held stake through Opaleye, L.P. to 3,054,853 shares.
1. Share purchase
Opaleye Management purchased 18,442 shares of Grace Therapeutics common stock. The purchases increased its indirectly held stake through Opaleye, L.P. to 3,054,853 shares.
